NN Investment Partners Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.11M Sell
29,217
-88
-0.3% -$6.34K 0.01% 538
2021
Q4
$2.69M Buy
29,305
+4,537
+18% +$542K 0.01% 513
2021
Q3
$3.14M Buy
+24,768
New +$3.61M 0.02% 500
2018
Q2
Sell
-200,000
Closed -$8.06M 657
2018
Q1
$8.06M Buy
200,000
+30,000
+18% +$1.13M 0.06% 239
2017
Q4
$5.92M Buy
170,000
+10,000
+6% +$332K 0.04% 281
2017
Q3
$5.3M Buy
+160,000
New +$5.25M 0.03% 326

Other funds holding TDOC

NN Investment Partners Holdings's TDOC Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Teladoc Health (TDOC) stake by 0.3% in Q1 2022, selling an estimated $6.34K and leaving 29,217 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #538.

NN Investment Partners Holdings first reported a position in TDOC in Q3 2017 and has held it in 6 quarters since. The position peaked at $8.06M in Q1 2018. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • NN Investment Partners Holdings held 29,217 shares of Teladoc Health worth $2.11M as of Q1 2022.
  • NN Investment Partners Holdings sold 88 Teladoc Health shares in Q1 2022, an estimated $6.34K.
  • Teladoc Health made up 0.01% of NN Investment Partners Holdings's portfolio in Q1 2022, its #538 holding.
  • NN Investment Partners Holdings first reported a position in Teladoc Health in Q3 2017 and has held it in 6 quarters since.
  • NN Investment Partners Holdings's Teladoc Health position peaked at $8.06M in Q1 2018.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.